InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Carboat post# 194564

Sunday, 10/19/2014 10:49:09 PM

Sunday, October 19, 2014 10:49:09 PM

Post# of 346050

peer reviewed publications wit bavi or pphm as subject?



Peer review publications where "Phosphatidylserine" plays a major role in why many of "conclusions" ended in "... needs further research" or "... unclear why xyz happened..." or "... unclear of the role that phosphatidylserine plays in xyz..." or...on and on

I've already confirmed that once the MOA of bavi and PS Targeting further known, many of those 1,000's of publications would likely revisit their findings, though this time use a PS targeting agent and watch success in front of their eyes and watch as many conclusions are then updated to basically saying: "ATTENTION: PS TARGETING REQUIRED!!" : )

Watch for hundreds upon hundreds of new PS Targeting research and peer reviewed articles to come along.. its only a matter of time

If I was an academic researcher/scientist that spent my life on finding just a piece of the puzzle for a cure for just one disease and my research came to a crumbling halt because I didn't have a clue about the chain of events that Notch Signaling or cascade of events that would occur after targeting flipped PS, I'd do it again, only this time with a PS Targeting agent. Big Pharma can't buy them all... since "all" have a someone affected by cancer or hundreds of autoimmune diseases. Change is coming Big Pharmas way and it includes PS Targeting, every bit of the way.

I wonder how many are already in the process of duplicating their research and experiements, only by adding a little PS targeting to the equation? : )

Remember SK's words: "..get Bavi into as many hands as possible"

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News